Literature DB >> 33421074

Psychometric Assessment of the Connor-Davidson Resilience Scale for People With Lower-Limb Amputation.

Matthew J Miller1,2, Meredith L Mealer3,4, Paul F Cook5, Andrew J Kittelson6, Cory L Christiansen3,7.   

Abstract

OBJECTIVE: The purpose of this study was to (1) determine the psychometric properties of the 25- and 10-item Connor-Davidson Resilience Scales (CD-RISC25, CD-RISC10) for people with lower-limb amputation (LLA) in middle age or later, and (2) describe relationships of the CD-RISC with biopsychosocial, sociodemographic, and health variables.
METHODS: Participants were included if their most recent LLA was 1 or more years prior, if they were independently walking with a prosthesis, and if they were between 45 and 88 years of age (N = 122; mean = 62.5 years of age [SD = 8]; 59.5 [mean = 58] months since LLA; 88.5% male; 82.0% with dysvascular etiology; 68.0% with unilateral transtibial LLA). Psychometric analyses included assessment of skewness, floor and ceiling effects, internal consistency, and agreement between versions. Correlation analyses were used to determine associations between the CD-RISC with disability, perceived functional capacity, falls efficacy, life-space, anxiety, depression, self-efficacy, social support, sociodemographic, and health variables. Additionally, quartiles of participants were identified using CD-RISC25 and CD-RISC10 scores and compared using ANOVA and post-hoc comparisons for disability, perceived functional capacity, falls efficacy, and life-space.
RESULTS: Skewness, floor, and ceiling effects of both CD-RISC versions were acceptable. Both versions of the CD-RISC were internally consistent (CD-RISC25: α = .92; CD-RISC10: α = .89). The CD-RISC25 and CD-RISC10 were highly correlated with disability, perceived functional capacity, falls efficacy, anxiety, depression, and self-efficacy (r = 0.52-0.67). CD-RISC25 and CD-RISC10 quartile differences, especially the lowest quartile, were identified for disability, perceived functional capacity, falls efficacy, and life-space.
CONCLUSION: The CD-RISC25 and CD-RISC10 have acceptable psychometric properties for use with people who have LLA. CD-RISC scores are associated with clinically relevant biopsychosocial measures targeted by physical therapist intervention following LLA. IMPACT: The CD-RISC may be an appropriate tool to measure resilience following LLA. Published by Oxford University Press on behalf of American Physical Therapy Association 2021.

Entities:  

Keywords:  Coping; Lower Extremity Amputation; Psychometrics; Psychosocial; Resilience

Mesh:

Year:  2021        PMID: 33421074      PMCID: PMC8023555          DOI: 10.1093/ptj/pzab002

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  52 in total

1.  Measuring life-space mobility in community-dwelling older adults.

Authors:  Patricia S Baker; Eric V Bodner; Richard M Allman
Journal:  J Am Geriatr Soc       Date:  2003-11       Impact factor: 5.562

2.  Developing the World Health Organization Disability Assessment Schedule 2.0.

Authors:  T Bedirhan Ustün; Somnath Chatterji; Nenad Kostanjsek; Jürgen Rehm; Cille Kennedy; Joanne Epping-Jordan; Shekhar Saxena; Michael von Korff; Charles Pull
Journal:  Bull World Health Organ       Date:  2010-05-20       Impact factor: 9.408

Review 3.  Resilience: one part recovery, two parts sustainability.

Authors:  Alex J Zautra
Journal:  J Pers       Date:  2009-10-06

4.  Factors influencing participation in physical activity after dysvascular amputation: a qualitative meta-synthesis.

Authors:  Matthew J Miller; Jacqueline Jones; Chelsey B Anderson; Cory L Christiansen
Journal:  Disabil Rehabil       Date:  2018-09-27       Impact factor: 3.033

5.  Qualitative analysis of resilience characteristics of people with unilateral transtibial amputation.

Authors:  Matthew J Miller; Meredith L Mealer; Paul F Cook; Noel So; Megan A Morris; Cory L Christiansen
Journal:  Disabil Health J       Date:  2020-04-08       Impact factor: 2.554

6.  Prosthesis evaluation questionnaire for persons with lower limb amputations: assessing prosthesis-related quality of life.

Authors:  M W Legro; G D Reiber; D G Smith; M del Aguila; J Larsen; D Boone
Journal:  Arch Phys Med Rehabil       Date:  1998-08       Impact factor: 3.966

7.  The association between objectively measured physical activity and life-space mobility among older people.

Authors:  L-T Tsai; E Portegijs; M Rantakokko; A Viljanen; M Saajanaho; J Eronen; T Rantanen
Journal:  Scand J Med Sci Sports       Date:  2014-12-30       Impact factor: 4.221

8.  Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006.

Authors:  Rita Rastogi Kalyani; Christopher D Saudek; Frederick L Brancati; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

9.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

10.  Self-Efficacy and Social Support are Associated with Disability for Ambulatory Prosthesis Users After Lower-Limb Amputation.

Authors:  Matthew J Miller; Paul F Cook; Dawn M Magnusson; Megan A Morris; Patrick J Blatchford; Margaret L Schenkman; Cory L Christiansen
Journal:  PM R       Date:  2020-09-14       Impact factor: 2.298

View more
  2 in total

1.  Postamputation Cognitive Impairment Is Related to Worse Perceived Physical Function Among Middle-Aged and Older Prosthesis Users.

Authors:  Matthew J Miller; Rashelle M Hoffman; Laura A Swink; Deborah E Barnes; Cory L Christiansen
Journal:  Arch Phys Med Rehabil       Date:  2022-02-03       Impact factor: 4.060

2.  Psychometric properties of the Persian version of abridged Connor-Davidson Resilience Scale 10 (CD-RISC-10) among older adults.

Authors:  Hassan Rezaeipandari; Asghar Mohammadpoorasl; Mohammad Ali Morowatisharifabad; Abdolreza Shaghaghi
Journal:  BMC Psychiatry       Date:  2022-07-23       Impact factor: 4.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.